PHARMACEUTICAL PREPARATIONS TEMPORARY RELIEF

Brand Owner (click to sort) Address Description
ARMSTRONG ARMSTRONG PHARMACEUTICALS, INC. 25 John Road Canton MA 02021 Pharmaceutical preparations for temporary relief or treatment of certain respiratory conditions for use in connection with humans;
FLEET RELIEF C.B. FLEET COMPANY, INCORPORATED 4615 Murray Place Lynchburg VA 24502 Pharmaceutical preparations for temporary relief from itching and discomfort associated with hemorrhoids and other anorectal disorders;RELIEF;
FLEET RELIEF C.B. FLEET COMPANY, INCORPORATED 4615 Murray Place Lynchburg VA 24502 PHARMACEUTICAL PREPARATIONS FOR TEMPORARY RELIEF FROM ITCHING AND DISCOMFORT ASSOCIATED WITH HEMORRHOIDS AND OTHER ANORECTAL DISORDERS;relief;
FLEET RELIEF C.B. FLEET COMPANY, INCORPORATED 4615 Murray Place Lynchburg VA 24502 pharmaceutical preparations for temporary relief from itching and discomfort associated with hemorrhoids and other anorectal disorders;RELIEF;
NICEASE Alternative Tobacco Products, Inc. 200 West 17th Street Suite 80 Cheyenne WY 82001 Pharmaceutical preparations for temporary relief of tobacco related withdrawal symptoms;
PRIMATENE ARMSTRONG PHARMACEUTICALS, INC. 25 John Road Canton MA 02021 Pharmaceutical preparations for temporary relief of mild symptoms of intermittent asthma;
PRIMATENE MIST ARMSTRONG PHARMACEUTICALS, INC. 25 John Road Canton MA 02021 Pharmaceutical preparations for temporary relief of mild symptoms of intermittent asthma;MIST;
VAGITROL New Pharma, Inc. 3307 NW 74th Avenue Miami FL 33122 Pharmaceutical preparations for temporary relief of feminine itching;
VIOFORM New Pharma, Inc. 3307 NW 74th Avenue Miami FL 33122 Pharmaceutical preparations for temporary relief of itching associated with minor skin irritations, inflammation, and rashes due to eczema, psoriasis, jewelry, insect bites, detergents, seborrheic dermatitis, cosmetics, and soaps;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.